News
Bausch & Lomb Reports Weak Start to 2025 as enVista Recall, Tariffs, and Drug Pricing Cause Concerns
Bausch & Lomb is one of the largest vision care companies in the US. Bausch spun off from its former parent company, Bausch Health, in 2022 and it now operates in three segments: vision care, surgical ...
New long-term data on Essilor Stellest spectacle lenses show efficacy in slowing myopia progression for up to 6 years in ...
The Alabama House unanimously passed HB176 to exempt prescribed eyeglasses and contact lenses from state sales tax, sending ...
Detailed price information for Bausch Lomb Corporation (BLCO-T) from The Globe and Mail including charting and trades.
Ghent-based Azalea Vision, a health tech company, announced the first closing of its €15M Series A funding round.
Summer 2025, CARRERA introduces new, bold and contemporary sunglasses always iconic thanks to the unmistakable details of the ...
Bausch + Lomb announced today that it intends to bring its recently recalled enVista intraocular lenses (IOLs) back to the ...
The global market for scleral lenses is witnessing a significant upswing, with a projected compound annual growth rate (CAGR) of 6.3% over the next decade. According to a recent report by Future ...
The Vision Council has proudly served as Secretariat for ASC Z80, supporting the development and management of national ...
Most everyone can find frames they like and lenses that suit their prescription at Eyebuydirect. Prices are in the mid-range, and the return period is shorter than most, but our testers ...
These include the ZEISS ARTEVO 850 and ARTEVO 750 ophthalmic microscopes, the AT ELANA® 841P trifocal Intraocular Lens (IOL), and the ZEISS CIRRUS PathFinder AI decision support tool - all designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results